Up-regulation of transcription factor 3 is correlated with poor prognosis in cervical carcinoma
International Journal of Gynecological Cancer Sep 04, 2017
Luo L, et al. – The scientists explored the expression level of transcription factor 3 (TCF3) in patients with cervical squamous cell carcinoma (CSCC). Their investigations revealed that TCF3 was clearly associated with the progression of CSCC. Thus, it could be used as a biomarker to determine the prognosis of CSCC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
